What this is
- This research investigates health inequities in () care, focusing on socially excluded populations.
- It employs qualitative interviews and quantitative data from primary care records to explore access barriers.
- The study identifies strategies to improve inclusivity in healthcare services and highlights the need for better support for disadvantaged groups.
Essence
- Health inequities in care impact socially excluded populations, with barriers to access and referral identified. Strategies to improve inclusivity in healthcare services are necessary.
Key takeaways
- Participants from disadvantaged groups reported delays in diagnosis and low trust in healthcare services. Barriers included inadequate information and support, leading to under-referral to specialist care.
- Primary care data indicated low overlap between diagnoses, referrals to clinics, and attendance. Only 4.4% had records of all three, highlighting systemic issues in care pathways.
- Some clinics implemented strategies to improve access for underserved groups, but these practices were not widespread. Increased collaboration between clinics and community organizations is recommended.
Caveats
- The study faced limitations due to incomplete data on disadvantaged groups, which hindered comprehensive analysis of referral patterns. Recruitment challenges, particularly with homeless individuals, also impacted findings.
- The exploratory nature of the study means that evidence of the effectiveness of inclusion initiatives is limited, necessitating further research to evaluate these interventions.
Definitions
- Long Covid (LC): Persistent COVID-19 symptoms lasting more than 4 weeks after acute infection, significantly affecting daily activities.
AI simplified
Introduction
Long Covid (LC) is defined as persistent COVID‐19 symptoms more than 4 weeks after acute infection and is a growing global problem [1]. Commonly reported symptoms can adversely affect day‐to‐day activities significantly [2] and include fatigue, cognitive dysfunction, shortness of breath, pain and mood problems [3, 4]. LC also impacts economic, social and caring activities [5].
LC affects around 200 million people worldwide [6], including almost 2 million in the United Kingdom [3]. A recent meta‐analysis indicated that 45% of COVID‐19 survivors experienced unresolved symptoms at around 4 months [7]. Among working‐age people, the likelihood of economic inactivity after a confirmed COVID‐19 infection was significantly higher than before infection [8, 9].
Large studies on the prevalence of LC show higher rates in economically deprived, learning disability, homeless and some minority ethnic populations [4, 10], who are also more likely to have underlying health conditions and experience social isolation [11]. A significant body of evidence links health inequalities in these groups to reduced access to support or involvement in decision‐making about their health and poorer quality healthcare compared to the general population [12, 13, 14]. Similar barriers have been reported by people with LC from such groups, including unresponsive services, inadequate support and mistrust or fear linked to negative interactions with healthcare providers [15, 16, 17].
Reducing health inequalities for people with LC is a key aim of the National Health Service (NHS) LC Plan 2021/22 [18] which promotes the use of clinical data, engagement with communities, culturally competent services and multiagency collaboration (Figure 1).
We aimed to explore the experience of access to LC healthcare for people from socially excluded populations and identify inclusion strategies that address inequities in LC care. We examined whether these strategies aligned with the priorities of people with LC and identified examples of good practice from clinics within the LOCOMOTION research consortium [19] that could inform current practice and future research.

NHS LC Plan for reducing inequality.
Methods
Using a mixed‐methods approach, we explored diverse stakeholder perspectives on inclusive LC support for members of socially marginalised groups. In 2021–3, qualitative interviews were conducted with individuals from across the United Kingdom. In 2023, data were collected from primary care records and LC clinics.
Study Participants and Design
Semi‐structured interviews were used to gather qualitative data from individuals in populations identified as underserved [20]. We focused on people with LC who could recall their COVID‐19 infections and subsequent LC symptoms, aged 18 or over and from a range of disadvantaged populations: people from deprived and minority ethnic backgrounds, women, homeless people and people with disabilities; we did not prioritise specific participants within or between these groups. We purposefully recruited through community organisations, posters in GP surgeries, researchers' personal networks and snowballing, particularly targeting individuals who did not attend LC clinics. Participants received a study information sheet, gave informed consent for interviews and received an involvement fee for participation. Interviews explored experiences of LC and any support received in relation to diagnosis, treatment and management (see Supporting Information1). Academic, policy and practice experts in LC and inequalities ('Key Informants') were also recruited using purposive sampling. These interviews explored issues relating to healthcare access and other issues relevant to inequalities, such as the impact of multiple forms of disadvantage (see Supporting Information2).
NVivo 14 software was used to code data and help develop themes using the framework analysis tools of familiarisation, identifying themes and codes, charting, mapping and interpretation [21]. J.M. and G.M. double coded 10% of transcripts and compared themes and codes to agree on a coding framework. We discussed the themes with our PAG and lived experience advisers, after which J.M. coded the remaining transcripts and charted the coded data. J.M. and G.M. then used data charts to map participant experiences and views, interpret the data as a whole and develop findings. Quotations were selected to highlight common and specific experiences that had implications for LC policy or practice development. All interviews were conducted by J.M.; joint coding and interpretation of data by J.M. and G.M. aimed to ensure rigour in data analysis processes and our final interpretations [ibid].
This analysis informed a survey of 10 LC specialist clinics to identify initiatives for addressing inequalities in terms of demographic data collection and analysis and use of such data (see Supporting Information3). A description of how these clinics operated is provided elsewhere [22]. Healthcare staff in these clinics, along with people with lived experience of LC, were involved in a Quality Improvement Collaborative at which findings from our qualitative interviews were discussed [22]. A questionnaire was designed to identify the extent to which clinics were aware of inequalities in access to specialist healthcare, challenges to data collection and examples of inclusion initiatives being undertaken to help reduce inequalities.
Primary care data were obtained from the Whole Systems Integrated Care (WSIC) dataset, which comprises individual records of over 2.7 million patients from GP practices in North West (NW) London. These data were linked, using a unique pseudonymised patient identifier from the NHS number to hospital Secondary Uses Service data containing records of appointments, accident and emergency attendances and inpatient admissions to hospitals across England. Patients were identified as having a recorded diagnosis of LC if their primary care record contained one of four LC Systematized Nomenclature of Medicine (SNOMED) clinical terms between 1 January 2020 and 30 September 2023.
Our qualitative findings also informed the analysis of primary care data, which focused on LC care pathways for diverse populations. Demographic variables (sex, ethnicity and socioeconomic status based on the Index of Multiple Deprivation ranks) were compared between patients with and without an LC diagnosis. Descriptive statistics were generated, and the concordance between a primary care diagnosis of LC, LC clinic referrals and attendance at appointments was evaluated. For each patient, the frequency with which one, two or three of an LC diagnosis, LC clinic referral or LC clinic attendance were present was identified and used to construct a Venn diagram. Data extraction was performed using Microsoft SQL Server Management Studio 2018, while data processing and analysis were conducted in Python (v3.7.9) using the Pandas (v1.3.2) and numpy (v1.19.5) libraries.
Findings from the survey and primary care data were combined with qualitative data findings to identify common themes across the three data sources and explain, confirm or enhance findings from each source [23]. We then drew on this triangulation of findings to suggest potential ways forward for how inequities could be addressed. Oversight was provided by the LOCOMOTION Data Management Group, with additional input from the LOCOMOTION Patient Advisory Group, of which S.E. is a member.
Results
Qualitative Findings
Qualitative interview data were obtained from 23 people living with LC (PWLC) from underserved groups and 18 academic or healthcare experts in LC and inequalities (Key Informants—KIs). Demographic details of these participants and more details of their experience of diagnosis have been published elsewhere [15]. The recruitment process encountered challenges in engaging homeless individuals. Specialist general practitioners (GPs) and voluntary sector organisations indicated that homeless individuals were less likely to associate LC symptoms with COVID‐19, due in part to symptom overlap with drug and alcohol addiction and a lack of diagnostic testing. Additionally, immediate financial, housing and social concerns were reported to take precedence over participation in research, even though involvement fees were offered to all people with LC.
Barriers to LC Support
People with LC identified several barriers to accessing support for LC, including unresponsive services in which they were not believed or supported by GPs or referred for specialist care. There was also a general deficiency in LC‐related knowledge among both patients and primary care providers, and some people with LC expressed mistrust towards healthcare professionals, based on personal or previous community experiences of discrimination. The lack of diagnosis was a cause of considerable emotional distress for people with LC [15] and further complicated interactions with employers, who often did not acknowledge 'invisible' symptoms such as fatigue, pain and cognitive dysfunction [8] (see Box 1: Barriers to LC support).
KI participants working in LC healthcare and academia confirmed these dynamics: 'the attitudes of health professionals affect access as well. So if I see you and pigeonhole you as a woman of a certain age and likely to be more on the functional disease spectrum ‐ and there are people who have these views ‐ then I'm less likely, even if there is a LC clinic, then I'm less likely to refer you to it.[…] we know from the first wave that people from certain ethnic minority backgrounds didn't trust the health system […] in terms of vaccination strategy, in terms of the acute waves of the pandemic. They don't trust what the hospitals are doing, what the government is doing, what the GP is doing. And they're going to be difficult to get to the LC clinic'. KI06, clinical academic and cardiologist There's a lot of knowledge that's missing. I think that is probably one of the big drivers about who is self‐reporting […] and who can advocate for it KI10, Community Health Practitioner
Referral to Specialist Care
Where referrals were made to secondary care, this was often to a range of separate clinics dealing with individual symptoms rather than to specialist care for LC. Various tests might be organised through these referrals; however, if these returned normal results, care would end without an overview of the combination of symptoms that an individual experienced (see Box : Inappropriate care pathways). 1
Ten of our participants with LC, mostly healthcare professionals, did manage to organise a referral for specialist care after considerable persistence, using knowledge of NHS provision from within their own networks. What was clear from people with LC (PWLC), however, was that most respondents did not have the necessary energy or resources for such engagement [15] and were left feeling frustrated and neglected (Box 1 PWLC01).
LC Clinic Data
Feedback from professionals working in specialist LC clinics revealed that there was a lack of demographic data in their records of people with LC. Only two of the ten sites were able to provide details of data collection on age, gender, ethnicity, deprivation, disability or homelessness. At one of these clinics, data on the first three categories and possibly a disability flag were recorded on the main record system, with other data recorded via free text that would be difficult to extract.
This context made it difficult to assess the extent of inequities in access to clinics and the impact of operational policies on disadvantaged groups. Only a minority of clinics, however, appeared to be taking steps to address this issue. In a clinic that did collect comprehensive demographic data, under‐representation of people with LC from deprived, ethnic minority and learning disability groups was noted, along with poor referral of these groups from primary care practitioners. No clinic in our sample had any coded record of people with LC with a learning disability, despite the known higher prevalence in this population [24].
Findings From Primary Care Data
Analysis of the larger dataset from primary care practices in NW London indicated better data collection for most excluded groups. Homeless people were identified using a collection of SNOMED codes that encompass homelessness, rough sleeping and temporary lodging circumstances. People were identified by the presence of any of the related codes in the period of 3 years before LC diagnosis. In total, 35 homeless people with LC were identified (0.75% of all people with LC). Despite the existence of clinical codes for learning disability and the higher prevalence of LC associated with both these groups [3, 24], it was not possible to identify sufficient people to include these groups in our analysis.
The socio‐demographic profile of this overall population and those with a recorded diagnosis of LC is published elsewhere [25]. This earlier analysis found that a diagnosis was more likely to be recorded in primary care for women and people from Asian backgrounds or mixed ethnicity than for people from white backgrounds. Surprisingly, a higher risk of LC was found for those in our sample who lived in the third and fourth most deprived quintiles than for those in the most deprived quintile [25].
Further analysis of the dataset for this paper found low overlap between data on people with an LC diagnosis in primary care, referral to an LC clinic and LC clinic attendance. There were 7060 individuals with a record of either an LC diagnosis, LC clinic referral or LC clinic attendance; however, only 4.4% had records of all three. Over half (54.8%) had only a record of LC in their primary care without a record of LC clinic referral or attendance, while 68.1% of those either referred to or seen in an LC clinic did not have an LC diagnosis in their primary care record. This lack of overlap is visually represented in Figure 2.
While not all people with LC may require onward specialist referral, Figure 2 indicates there is low referral in general for specialist LC care and probable incompleteness of LC data across different clinical pathways. A broader issue is also raised in terms of the general population of those with LC who are referred to clinics but do not subsequently attend. The lack of data for LC clinics prevented further demographic analysis of these groups. Feedback from our LC clinic leads, however, suggested this pattern of under‐referral particularly impacted those from disadvantaged groups, and our qualitative data highlighted problems with access to specialist care for these populations. The findings from primary care data indicate a lack of overall alignment of data sources across the LC care pathway, which limits opportunities to understand the equity of provision for LC healthcare using administrative health record data alone.

Overlap between recording of LC diagnoses, referral to LC clinics and LC clinic attendance.
What Good Practice Exists?
We found examples of inclusive practice from some clinics that had self‐assessed for inequities in access and were actively seeking to address these (Box 2). Two case studies (Boxes 3 and 4) provide an overview of inclusive approaches used within clinics adopting a strategic approach. Although formal evaluation of these initiatives by clinics was limited, there is considerable existing evidence that the approaches described can help reduce inequalities in healthcare and other public services [13].
Discussion
Summary
A growing body of evidence highlights health inequalities in the prevalence and experience of LC in socially excluded groups, but evidence about practice initiatives to reduce inequalities is lacking. Our findings triangulate data from diverse sources to provide insight into patterns of LC diagnosis and referral in primary care, along with practical initiatives to address inequalities in access to specialist healthcare. We provide initial evidence that these initiatives could improve access for deprived and minority ethnic groups, but there is a substantial need for more detailed evaluation.
Strengths and Limitations
Involvement of people with LC in the research design and evaluation of LC services is a key strength of the study. Our mixed‐methods approach brings together multiple data sources to triangulate and explore diverse perspectives on LC inequalities.
Quantitative data collection and analysis were informed by qualitative findings; however, this analysis was limited by the incomplete and patchy data on excluded groups from clinical pathways. In primary care, the small number of people from specific disadvantaged groups was a further barrier to analysing inequities between population groups. We were unable to recruit homeless people, but gained some insights into why LC is difficult to identify in this group of people with LC. As an exploratory study, we had very limited evidence of the success of inclusion initiatives, and further research to evaluate these interventions is needed.
Comparison With Existing Literature
Accessing healthcare support for LC is reported as a problem for many people with LC [16, 26]; however, our findings reflect the additional disadvantage for socially excluded groups highlighted in the wider literature on Covid‐19: being accorded low credibility by healthcare practitioners, inadequate information about LC and available support, and mistrust of the healthcare system [27, 28].
Some LC studies have utilised the concept of epistemic injustice to better understand the process through which individuals' explanations of their symptoms are ignored and the harms caused by misrecognition [15, 29, 30]. Such injustice includes a racialised and gendered element for minority ethnic and female people with LC, who can feel both ignored in terms of inadequate information and care and also worried that they are being neglected because of their ethnic background or sex. This uncertainty is an important consideration for ethnic minorities and women navigating healthcare, creating doubt about the basis on which healthcare professionals respond or provide treatment [31]. KIs described how discrimination and inadequate information were linked to systemic injustice, mistrust and under‐representation in LC specialist care. This dimension of social exclusion goes beyond the usual power imbalance between those receiving care and healthcare practitioners, adding concerns about how much service users can trust practitioners [15]. Involving community advocacy groups in the referral pathway for LC care seems a promising good practice initiative, given that expertise in engaging marginalised groups is most likely to be found in third sector organisations [17, 32].
Failure to refer from primary care to specialist support is a further key issue for people with LC from underserved groups, exacerbating the potential mistrust in practitioners and creating further downstream consequences for health‐seeking behaviour in these populations [15, 28]. Our findings on barriers to LC support may help explain the lower rate of LC diagnosis found in primary care records for the most deprived quintile [25]. The lack of overlap between primary care and LC clinic data aligns with other recent work highlighting the probable under‐reporting of LC diagnosis in primary care, particularly for minority ethnic groups [33].
The good practice initiative to improve consistency in LC healthcare decision‐making (Box 4) is likely to be helpful in addressing the higher prevalence of LC among deprived and some minority ethnic populations found in studies with large samples [4, 25, 35]. One study suggests that a focus on symptoms rather than self‐report could better expose inequalities [4], and this approach could potentially add to evidence that LC symptoms may differ between ethnic groups [36, 37].
Being able to access support for LC involves navigating the healthcare system; this requires high levels of social capital and what Janet Shim [38] has termed 'cultural health capital'. Shim defined this as:'the repertoire of cultural skills, verbal and nonverbal competencies, attitudes and behaviours, and interactional styles, cultivated by patients and clinicians alike, that, when deployed, may result in more optimal health care relationships. I consider cultural health capital alongside existing frameworks for understanding clinical interactions, and I argue that the concept of cultural health capital offers theoretical traction to help account for several dynamics of unequal treatment'.(Shim, 2010: 1)
This definition is useful for better understanding the experiences of underserved communities living with LC, not least because it describes the kind of confidence, attributes and networks needed to navigate healthcare encounters with clinicians to receive appropriate care [15]. It also highlights the role of the clinician in shaping equitable encounters. If practitioners deploy attitudes and behaviours that discriminate rather than ensure optimal care, the encounter could reduce the confidence of health service users and negatively affect their interactions, restricting their cultural health capital in the process.
Implications for Research and/or Practice
Our triangulated findings, which include the perspective of those least likely to shape healthcare services, demonstrate that access to specialist support is a key issue for equitable provision in LC healthcare. The higher likelihood of being diagnosed with LC for minority ethnic and deprived people with LC does not translate to higher rates of referral to specialist LC care, according to those with lived experience of LC and clinic staff in our sample. A single point of entry to LC care pathways via GPs was, consequently, inadequate, and involving community advocacy groups in referrals showed positive impacts on access.
The use of a protocol focused on symptoms reported by people with LC to aid referral decisions is also promising in terms of existing research as well as our qualitative findings [39]. This approach reduces practitioner inconsistency and accords with effective methods for removing discriminatory practice which may affect excluded populations [13] as well as reducing an over‐reliance on self‐report. Our findings suggest that self‐report is less likely for populations that experience mistrust in healthcare providers and barriers to accessing knowledge and information about LC symptoms.
Evaluation of inclusion initiatives requires good‐quality data and resources for analysis [12]. Data quality, particularly in LC specialist care, is currently a stumbling block to assessing health outcomes, as there is no way of linking data from specialist centres to Electronic Health Records. The low numbers of people with an LC diagnosis being referred to specialist clinics, and even lower numbers attending appointments, make it even more difficult to assess the effectiveness of access initiatives by specialist centres. The paucity of qualitative or clinical data on homeless people with LC further highlights the invisibility of this population and signals an urgent need to identify such individuals and specifically target their care.
Conclusions and Recommendations
A key recommendation arising from our research is increased collaboration between LC clinics, third sector organisations and GPs to increase awareness and validation of LC, trust in healthcare and consistency of access to LC support, all of which could improve access to specialist LC care. Such initiatives are particularly important for those with low levels of health literacy and least capacity to persevere with requests for support.
In terms of care pathways, evidence from qualitative interviews and clinical data highlights the fragmented nature of the care people with LC could receive. This suggests that the integrated and multidisciplinary care pathway operated in NW London is an appropriate approach to diagnosis, referral and treatment of LC. Qualitative findings suggest that such collaboration across clinical teams could particularly benefit those who experience a range of symptoms, particularly if these fluctuate over time.
Some of the inclusive practice initiatives we identified within LC clinics such as Leeds are currently promoted within NHS LC policy [18]; however, our findings suggest there is a need for more implementation support, as these initiatives were not often utilised in practice. The LC policy should also more clearly promote collaboration between diverse specialities and sectors within the NHS as well as work to create links across sectors.
Author Contributions
Ghazala Mir: conceptualisation, methodology, data curation, formal analysis, supervision, funding acquisition, writing – original draft, writing – review and editing, project administration, visualisation. Jordan Mullard: investigation, validation, formal analysis, project administration, writing – original draft, writing – review and editing, visualisation. Amy Parkin: writing – review and editing, investigation. Cassie Lee: writing – review and editing, investigation, validation, formal analysis. Jonathan Clarke: data curation, formal analysis, investigation project administration, writing – review and editing, writing – original draft, funding acquisition, methodology, visualisation. Johannes H. De Kock: writing – review and editing. Denys Prociuk: formal analysis, writing – original draft, writing – review and editing, data curation, investigation, visualisation. Julie L. Darbyshire: writing – review and editing. Sophie Evans: writing – review and editing, supervision, validation. Manoj Sivan: conceptualisation, methodology, data curation, supervision, funding acquisition, project administration, writing – review and editing.
Disclosure
The views expressed in this publication are those of the authors and not necessarily those of NIHR or the Department of Health and Social Care.
Ethics Statement
Bradford Leeds Research Ethics Committee (reference: 21/YH/0276) and the Health Research Authority Confidentiality Advisory Group under reference: 303623.
Consent
Patient consent was obtained for all qualitative data interviews. All necessary permissions were obtained from the HRA and Whole Systems Integrated Care Data Access Group for anonymised primary care data use.
Conflicts of Interest
The authors declare no conflicts of interest.